
Chinese company gets approval for ADHD drug clinical trial
Beijing Huasu Pharmaceutical Co. has received approval to conduct clinical trials for a sustained-release chewable tablet of methylphenidate hydrochloride for ADHD treatment.
Quorum · collective opinions
Chinese Pharmaceutical Company's ADHD Drug Trial Approval
First report 3h agoLast update 3h agoThe announcement details the approval for clinical trials of a generic ADHD drug, marking a significant step for the company in a market currently dominated by one imported original drug.
iWitness comments
No comments yet — be the first to weigh in.